-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Neurological drugs
Category:
Time: 2021-11-20
【SUMMARY】
| Drug Name | Specifications | Rank | Type |
|---|---|---|---|
| Bunanserine Tablets | 4mg | The first exclusive | New Category 4 |
| Lacosamide Tablets | 50mg | New Category 4 | |
| Lacosamide Tablets | 100mg | New Category 4 | |
| Lacosamide Injection | 20 ml: 0.2 g | New Category 4 | |
| Lurasidone Hydrochloride Tablets | 40mg | New Category 4 | |
| Ropivacaine Hydrochloride Injection | 10 ml: 100 mg | New Category 4 | |
| Ropivacaine Hydrochloride Injection | 10 ml: 75 mg | The 3rd store | New Category 4 |
| Paracetamol Mannitol Injection | 100 ml: 1000 mg | The second store | New Category 3 |
| Dexmedetomidine Hydrochloride Injection | 2 ml: 0.2 mg | New Category 3 | |
| Dexmedetomidine Hydrochloride Injection | 1 ml: 0.1 mg | New Category 3 | |
| Citicoline Sodium Injection | 4 ml: 0.5 g | New Category 3 | |
| Stiripentol Dry Suspension | 500mg | First to pass the evaluation | New Category 3 |
| Stiripentol Dry Suspension | 250mg | First to pass the evaluation | New Category 3 |
Neurological drugs
Keywords:
Next:
More Announcements
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091